Holy COWS: precipitated opioid withdrawal treated with polypharmacy including high dose fentanyl

被引：0
|
作者：
Kunzler, Nathan [1 ]
Pueringer, Robert Cole [1 ]
Willenbring, Benjamin [1 ]
机构：
[1] Reg Hosp, Div Med Toxicol, Minneapolis, MN USA
来源：
CLINICAL TOXICOLOGY | 2021年 / 59卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R99 [毒物学（毒理学）];
学科分类号：
100405 ;
摘要：
28
引用
收藏
页码：1050 / 1050
页数：1
相关论文
共 50 条
  • [21] Tranq Dope: Characterization of an ED cohort treated with a novel opioid withdrawal protocol in the era of fentanyl/xylazine (vol 85, pg 130, 2024)
    London, Kory
    Li, Yutong
    Kahoud, Jennifer L.
    Cho, Davis
    Mulholland, Jamus
    Roque, Sebastian
    Stugart, Logan
    Gillingham, Jeffrey
    Borne, Elias
    Slovis, Benjamin
    AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2024, 86 : 191 - 191
  • [22] High-dose methadone produces superior opioid blockade and comparable withdrawal suppression to lower doses in opioid-dependent humans
    Donny, EC
    Walsh, SL
    Bigelow, GE
    Eissenberg, T
    Stitzer, ML
    PSYCHOPHARMACOLOGY, 2002, 161 (02) : 202 - 212
  • [23] High-dose methadone produces superior opioid blockade and comparable withdrawal suppression to lower doses in opioid-dependent humans
    Eric C. Donny
    Sharon L. Walsh
    George E. Bigelow
    Thomas Eissenberg
    Maxine L. Stitzer
    Psychopharmacology, 2002, 161 : 202 - 212
  • [24] Efficacy and Safety of Fentanyl Citrate Patch, Including a Low-Dose 0.5 mg Formulation, in Opioid-Naive Patients with Cancer Pain
    Yamaguchi, Shigeki
    Uchida, Eiji
    Terahara, Takaaki
    Okawa, Koji
    Hashimoto, Fumitaka
    Tanaka, Yusuke
    CLINICAL DRUG INVESTIGATION, 2020, 40 (11) : 1041 - 1052
  • [25] Outcomes of Patients with Alcohol Withdrawal Syndrome Treated with High-Dose Sedatives and Deferred Intubation
    Stewart, Robert
    Perez, Ricardo
    Musial, Bogdan
    Lukens, Carrie
    Adjepong, Yaw Amoateng
    Manthous, Constantine A.
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2016, 13 (02) : 248 - 252
  • [26] Efficacy and Safety of Fentanyl Citrate Patch, Including a Low-Dose 0.5 mg Formulation, in Opioid-Naïve Patients with Cancer Pain
    Shigeki Yamaguchi
    Eiji Uchida
    Takaaki Terahara
    Koji Okawa
    Fumitaka Hashimoto
    Yusuke Tanaka
    Clinical Drug Investigation, 2020, 40 : 1041 - 1052
  • [27] Reducing the dose of antipsychotic medications for those who had been treated with high-dose antipsychotic polypharmacy: an open study of dose reduction for chronic schizophrenia
    Suzuki, T
    Uchida, H
    Tanaka, KF
    Tomita, M
    Tsunoda, K
    Nomura, K
    Takano, H
    Tanabe, A
    Watanabe, K
    Yagi, G
    Kashima, H
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2003, 18 (06) : 323 - 329
  • [28] Successful withdrawal from high-dose benzodiazepine in a young patient through electronic monitoring of polypharmacy: a case report in an ambulatory setting
    Loscertales, Hector R.
    Wentzky, Valerie
    Dursteler, Kenneth
    Strasser, Johannes
    Hersberger, Kurt E.
    Arnet, Isabelle
    THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY, 2017, 7 (05) : 181 - 187
  • [29] Extracorporeal membrane oxygenation for cardiopulmonary failure following fentanyl analogue overdose treated with high-dose naloxone
    Litell, John
    Arens, Ann
    Love, Sara
    Spindler, Carrie
    Cole, Jon
    CLINICAL TOXICOLOGY, 2018, 56 (10) : 1009 - 1010
  • [30] Prescription of psychotropic drugs in incarcerated patients treated with methadone or high dose buprenorphine for opioid substitution therapy
    Escudero, P.
    Meroueh, F.
    Hebraud, C.
    Blayac, J. P.
    Peyriere, H.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2009, 23 : 51 - 52
12345